Kintor Pharmaceutical Limited (KNTPF)

USD 0.18

(0.0%)

Total Liabilities Summary of Kintor Pharmaceutical Limited

  • Kintor Pharmaceutical Limited's latest annual total liabilities in 2023 was 411.12 Million CNY , down -26.58% from previous year.
  • Kintor Pharmaceutical Limited's latest quarterly total liabilities in 2024 Q2 was 347.96 Million CNY , down 0.0% from previous quarter.
  • Kintor Pharmaceutical Limited reported annual total liabilities of 559.94 Million CNY in 2022, up 35.64% from previous year.
  • Kintor Pharmaceutical Limited reported annual total liabilities of 412.83 Million CNY in 2021, up 20.17% from previous year.
  • Kintor Pharmaceutical Limited reported quarterly total liabilities of 347.96 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Kintor Pharmaceutical Limited reported quarterly total liabilities of 548.63 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Kintor Pharmaceutical Limited (2023 - 2014)

Historical Annual Total Liabilities of Kintor Pharmaceutical Limited (2023 - 2014)

Year Total Liabilities Total Liabilities Growth
2023 411.12 Million CNY -26.58%
2022 559.94 Million CNY 35.64%
2021 412.83 Million CNY 20.17%
2020 343.54 Million CNY 87.0%
2019 183.71 Million CNY 6.86%
2018 171.92 Million CNY 277.8%
2017 45.5 Million CNY 45226.62%
2016 100.39 Thousand CNY -74.18%
2015 388.8 Thousand CNY -2.07%
2014 397.01 Thousand CNY 0.0%

Peer Total Liabilities Comparison of Kintor Pharmaceutical Limited

Name Total Liabilities Total Liabilities Difference
Bioxytran, Inc. 3.24 Million USD -12551.793%
Eiger BioPharmaceuticals, Inc. 53.3 Million USD -671.26%
Institute of Biomedical Research Corp. 421.56 Thousand USD -97421.634%
SQZ Biotechnologies Company 50.03 Million USD -721.599%
Intellipharmaceutics International Inc. 12 Million USD -3323.499%
Evofem Biosciences, Inc. 72.47 Million USD -467.289%
Santhera Pharmaceuticals Holding AG 59.01 Million USD -596.648%
Propanc Biopharma, Inc. 3.85 Million USD -10574.493%
Marizyme, Inc. 26.67 Million USD -1441.177%
Genus plc 485 Million USD 15.233%
Pharming Group N.V. 244.07 Million USD -68.441%
Therapeutic Solutions International, Inc. 2.01 Million USD -20352.409%
CNBX Pharmaceuticals Inc. 2.51 Million USD -16238.093%
Nymox Pharmaceutical Corporation 3.8 Million USD -10718.947%
ContraFect Corporation 32.53 Million USD -1163.779%
RegeneRx Biopharmaceuticals, Inc. 3.82 Million USD -10640.8%
IMV Inc. 37.93 Million USD -983.812%
AXIM Biotechnologies, Inc. 11.77 Million USD -3390.518%
ONE Bio Corp. 27.49 Million USD -1395.21%
RVL Pharmaceuticals plc 77.41 Million USD -431.046%
Mesoblast Limited 188.44 Million USD -118.165%
MultiCell Technologies, Inc. 1617.67 USD -25414230.488%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 82.93 Million USD -395.714%
Genscript Biotech Corporation 1.32 Billion USD 68.992%
Neon Bloom, Inc. 1.22 Million USD -33427.617%
Mosaic ImmunoEngineering Inc. 5.14 Million USD -7889.063%
Nanobac Pharmaceuticals, Incorporated 9.58 Million USD -4190.535%
Biomind Labs Inc. 1.49 Million USD -27333.385%
Provectus Biopharmaceuticals, Inc. 9.04 Million USD -4446.684%
Oncotelic Therapeutics, Inc. 18.4 Million USD -2133.933%
Skye Bioscience, Inc. 14.07 Million USD -2821.499%
GlobeStar Therapeutics Corporation 1.43 Million USD -28572.235%
VioQuest Pharmaceuticals, Inc. 5.84 Million USD -6936.568%
THC Farmaceuticals, Inc. 142.09 Thousand USD -289227.563%
PsyBio Therapeutics Corp. 1.98 Million USD -20649.929%
Arch Therapeutics, Inc. 9.46 Million USD -4243.159%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 201.11 Thousand USD -204319.34%
Accustem Sciences Inc. 1.07 Million USD -37993.508%
EV Biologics, Inc. 2.11 Million USD -19337.664%
Q BioMed Inc. 8.13 Million USD -4954.999%
GB Sciences, Inc. 5.41 Million USD -7488.66%
Alpha Cognition Inc. 7.16 Million USD -5638.074%
CSL Limited 18.62 Billion USD 97.792%
Agentix Corp. 2.51 Million USD -16275.662%
American Oriental Bioengineering, Inc. 118.72 Million USD -246.287%
Enzolytics Inc. 365.26 Million USD -12.553%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. 67.39 Million USD -510.007%
Nuo Therapeutics, Inc. 838.73 Thousand USD -48916.849%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. 5.74 Million USD -7055.113%
argenx SE 444.95 Million USD 7.603%
Northwest Biotherapeutics, Inc. 74.92 Million USD -448.745%
HST Global, Inc. 593.59 Thousand USD -69159.577%
Enzon Pharmaceuticals, Inc. 1.71 Million USD -23885.998%
Wesana Health Holdings Inc. 1.25 Million USD -32549.483%
Halberd Corporation 728.71 Thousand USD -56316.808%
Endonovo Therapeutics, Inc. 24.74 Million USD -1561.358%
Inhibitor Therapeutics, Inc. 3.66 Million USD -11116.961%
Zenith Capital Corp. 27.56 Thousand USD -1491140.161%
RespireRx Pharmaceuticals Inc. 11.9 Million USD -3353.89%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 3.73 Million USD -10909.275%
AVAX Technologies, Inc. 3.99 Million USD -10194.097%
WPD Pharmaceuticals Inc. 680.83 Thousand USD -60284.763%
Cotinga Pharmaceuticals Inc. 2.71 Million USD -15061.299%
Ember Therapeutics, Inc. 238.65 Thousand USD -172166.126%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. 7.86 Million USD -5130.047%
Helix BioMedix, Inc. 66.92 Thousand USD -614162.876%
Capstone Therapeutics Corp. 50.26 Million USD -717.921%
Kadimastem Ltd 3.5 Million USD -11629.974%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 15.9 Million USD -2484.902%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 464.69 Thousand USD -88370.171%
Burzynski Research Institute, Inc. 27.43 Thousand USD -1498533.033%
LadRx Corporation 2.2 Million USD -18582.789%
Cell Source, Inc. 15.8 Million USD -2500.92%
ProtoKinetix, Incorporated 44.69 Thousand USD -919713.854%
Regen BioPharma, Inc. 5.45 Million USD -7432.959%
Regen BioPharma, Inc. 5.45 Million USD -7432.959%
Affymax, Inc. 8.87 Million USD -4534.427%
Mobile Lads Corp. 1.31 Million USD -31199.653%
Itoco Inc. 1.65 Million USD -24768.872%
Rasna Therapeutics, Inc. 2.05 Million USD -19939.336%
Pathfinder Cell Therapy, Inc. 6.04 Million USD -6696.495%
International Stem Cell Corporation 5.27 Million USD -7690.79%
CytoDyn Inc. 127.89 Million USD -221.454%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. 41.79 Thousand USD -983464.2%
NanoSphere Health Sciences Inc. 1.56 Million USD -26146.555%
Qrons Inc. 1.48 Million USD -27515.8%
Alseres Pharmaceuticals, Inc. 11.04 Million USD -3622.13%
SYBLEU INC 681.41 Thousand USD -60233.454%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 808.79 Thousand USD -50731.238%
Rebus Holdings, Inc. 5.24 Million USD -7742.808%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 6.1 Million USD -6637.568%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 625.8 Thousand USD -65594.165%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 4.61 Million USD -8804.242%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 40.99 Million USD -902.83%
Adhera Therapeutics, Inc. 22.26 Million USD -1746.486%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 2.02 Million USD -20198.343%
Innovation Pharmaceuticals Inc. 5.47 Million USD -7404.929%
Neutra Corp. 973.52 Thousand USD -42129.867%
Windtree Therapeutics, Inc. 29.01 Million USD -1316.922%
PureTech Health plc 125.58 Million USD -227.369%
Coeptis Therapeutics, Inc. 3.75 Million USD -10842.409%
IXICO plc 1.9 Million USD -21534.57%
IntelGenx Technologies Corp. 20.52 Million USD -1902.63%
Gelesis Holdings, Inc. 103.32 Million USD -297.894%
CSL Limited 18.62 Billion USD 97.792%
Cellectis S.A. 249.36 Million USD -64.864%